铁离子度与冠状动脉疾病有关:一项回顾性研究
Le Sun1,2, Guozhao Xia3, Sangyu Liang4
1Department of Rheumatology, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, Guangdong, China.
Medicine
|December 23, 2025
概括
在冠状动脉疾病 (CAD) 患者中,缺铁 (ID) 和贫血很常见. 智障与较差的心血管健康有关,并可能预测疾病严重程度,需要进一步调查.
科学领域:
- 心脏病学 心脏病学
- 血液学 血液学 血液学
- 内部医学 内部医学
背景情况:
- 心血管疾病 (CVD) 是全球发病率和死亡率的主要原因之一.
- 缺铁 (ID) 和贫血是心血管疾病患者经常出现的并发症,可能是心脏事件的前身.
- ID,贫血和冠状动脉疾病 (CAD) 之间的关系需要进一步阐明.
研究的目的:
- 调查怀疑冠状动脉疾病 (CAD) 的患者中缺铁和贫血的患病率.
- 在这个患者群体中确定与缺铁相关的因素.
- 探索铁缺乏症和CAD的临床表现之间的关联.
主要方法:
- 对313名成年患者进行了回顾性研究,这些患者因怀疑CAD而接受了侵入性冠状动脉血管造影.
- 基于欧洲心脏病学会指南的CAD诊断.
- 血清费里和转激素和度定义的ID;血红蛋白水平定义的贫血. 用于分析的多变量逻辑回归.
主要成果:
- 缺铁 (ID) 和贫血是普遍存在的,分别在32%和33%的患者中发现.
- 糖尿病独立地与贫血,糖尿病,心率升高,估计小膜过率降低和LDL胆固醇升高有关.
- ID与不稳定的心痛相关,与稳定的心痛和血管学冠状动脉样硬化相反.
结论:
- 在冠状动脉疾病 (CAD) 患者中,缺铁和贫血很常见.
- ID与不良的心血管风险因素和CAD的特定临床表现有关.
- 血清铁状况可能成为CAD的潜在预测因子,值得前性验证.
更多相关视频
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
5.8K
04:48Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry CE-ICP-MS for Quantification of Iron Redox Species FeII, FeIII
Published on: May 4, 2020
8.6K
相关概念视频
01:30Coronary Artery Disease I: Introduction
846
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
846
01:26Coronary Artery Disease II: Pathophysiology
336
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
336
01:30Acute Coronary Syndrome III: Diagnostic Studies
194
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
194
01:30Coronary Artery Disease III: Clinical Manifestations
299
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
299
01:26Coronary Artery Disease IV: Preventive Measures
564
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
564
01:27Coronary Artery Disease V: Interprofessional Care
203
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
203